Cargando…

Erratum: Author’s Affiliation Correction. Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor positive gastric cancer (World J Clin Cases 2019; Aug 6; 7 (15): 1964-1977)

Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacke...

Descripción completa

Detalles Bibliográficos
Autores principales: Kaito, Akio, Kuwata, Takeshi, Tokunaga, Masanori, Shitara, Kohei, Sato, Reo, Akimoto, Tetsuo, Kinoshita, Takahiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7674736/
https://www.ncbi.nlm.nih.gov/pubmed/33269289
http://dx.doi.org/10.12998/wjcc.v8.i21.5494
Descripción
Sumario:Correction to " Type II human epidermal growth factor receptor heterogeneity is a poor prognosticator for type II human epidermal growth factor receptor-positive gastric cancer" World J Clin Cases 2019; 7(15): 1964-1977. In this article, one of the affiliation of the first author was lacked. Akio Kaito, the first author, belonged to Course of Advanced Clinical Research of Cancer, Juntendo University Graduate School of Medicine, Tokyo 163-8001, Japan.